The immune privilege of the eye: Human retinal pigment epithelial cells selectively modulate T-cell activation in vitro

Current Eye Research

Volumn 30, Issue 5, 2005, Pages 375-383

  Kæstel, Charlotte G ^a   Lovato, Paota ^a   Ødum, Niels ^a   Nissen, Mogens H ^a   Röpke, Carsten ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

IL 2R; Inhibition; Proliferation; RPE; T cells

Indexed keywords

CD3 ANTIGEN; CD69 ANTIGEN; CD71 ANTIGEN; CYCLIN A; CYCLIN D; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 2 RECEPTOR BETA; INTERLEUKIN 2 RECEPTOR GAMMA; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PHYTOHEMAGGLUTININ; THYMIDINE;

ADULT; ARTICLE; CELL CULTURE; CELL CYCLE; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GAMMA IRRADIATION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; PERIPHERAL LYMPHOCYTE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANTIGENS, CD; ANTIGENS, CD3; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CELL CYCLE; CELL LINE; CELL PROLIFERATION; COCULTURE TECHNIQUES; DNA REPLICATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; IMMUNE SYSTEM; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; PIGMENT EPITHELIUM OF EYE; RECEPTORS, INTERLEUKIN; T-LYMPHOCYTES;

EID: 21344436842     PISSN: 02713683     EISSN: None     Source Type: Journal    
DOI: 10.1080/02713680590934120     Document Type: Article

References (33)

1. Wenkel H, Streilein JW. Evidence that retinal pigment epithelium functions as an immune-privileged tissue. Invest Ophthalmol Vis Sci. 2000;41:3467-3473.
2. Yoshida M, Takeuchi M, Streilein JW. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact. Invest Ophthalmol Vis Sci. 2000a;41:811-821.
3. Yoshida M, Kezuka T, Streilein JW. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 2. Generation of TGF-beta-producing regulatory T cells. Invest Ophthalmol Vis Sci. 2000b;41:3862-3872.
4. Streilein JW. Ocular immune privilege: the eye takes a dim but practical view of immunity and inflammation. J Leukoc Biol. 2003;74:179-185.
5. Jørgensen A, Wiencke A, la Cour M, Kaestel CG, Madsen HO, Hamann S, Ming LG, Scherfig E, Prause JU, Svejgaard A, et al. Human retinal pigment epithelial cells induce apoptosis in activated T cells. Invest Ophthalmol Vis Sci. 1998;39:1590-1599.
6. Rezai KA, Semnani RT, Farrokh-Siar L, Hamann KJ, Patel SC, Ernest JT, van Seventer GA. Human fetal retinal pigment epithelial cells induce apoptosis in allogenic T-cells in a Fas ligand and PGE2 independent pathway. Curr Eye Res. 1999;18:430-439.
7. Farrokh-Siar L, Rezai KA, Semnani RT, Patel SC, Ernest JT, Peterson EJ, Koretzky GA, van Seventer GA. Human fetal retinal pigment epithelial cells induce apoptosis in the T-cell line Jurkat. Invest Ophthalmol Vis Sci. 1999;40:1503-1511.
8. Farrokh-Siar L, Rezai KA, Semnani RT, Patel SC, Ernest JT, van Seventer GA. Human fetal retinal pigment epithelium suppresses the activation of CD4(+) and CD8(+) T-cells. Graefes Arch Clin Exp Ophthalmol. 1999;237:934-935.
9. Farrokh-Siar L, Rezai KA, Palmer EM, Patel SC, Ernest JT, van Seventer G.A. Human fetal retinal pigment epithelium-induced cell cycle arrest, loss of mitochondrial membrane potential and apoptosis. Invest Ophthalmol Vis Sci. 2000;413991-3998.
10. Jørgensen A, Junker N, Kaestel CG, Liang Y, Wiencke A, la Cour M, Lui, GM, Odum N, Nissen MH, Ropke C. Superantigen presentation by human retinal pigment epithelial cells to T cells is dependent on CD2-CD58 and CD18-CD54 molecule interactions. Exp Eye Res. 2001;73:723-733.
11. Kaestel CG, Jørgensen A, Nielsen M, Eriksen KW, Ødum N, Nissen MH, Röpke C. Human retinal pigment epithelial cells inhibit proliferation and IL2R expression of activated T cells. Exp Eye Res. 2002;74:627-637.
12. Liversidge J, McKay D, Mullen G, Forrester JV. Retinal pigment epithelial cells modulate lymphocyte function at the blood-retina barrier by autocrine PGE2 and membrane-bound mechanisms. Immunology. 1993;149:315-330
13. Liversidge J, Grabowski P, Ralston S, Benjamin N, Forrester JV. Retinal pigment epithelial cells produce nitric oxide in response to inflammatory cytokines and activated T cells. Immunology. 1994;83:404-409.
14. Marzio R, Mauel J, Betz-Corradin S. CD69 and regulation of the immune function, Immunopharmacol Immunotoxicol. 1999;21:565-582.
15. Braciale TJ, Braciale VL. Antigen presentation: structural themes and functional variations. Immunol Today. 1991;12:124-129.
16. Minami Y, Kono T, Miyazaki T, Taniguchi T. The IL-2 receptor complex: its structure, function, and target genes. Annu Rev Immunol. 1993:11:245-268.
17. Neckers LM, Cossman J. Transferrin receptor induction in mitogen-stimulated human T lymphocytes is required for DNA synthesis and cell division and is regulated by interleukin 2. Proc Natl Acad Sci USA. 1983;80:3494-3498.
18. Rabinovitch A, Torres RM, Engel D. Simultaneous cell cycle analysis and two-color surface immunofluorescence using 7-amino-actnimycin D and single laser excitation: applications to study of cell activation and cell cycle of murine LT-1 B cells. J Immunol. 1986;136:2769-2773.
19. Poulton TA, Gallagher A, Potts RC, Beck JS. Changes in activation markers and cell membrane receptors on human peripheral blood T lymphocytes during cell cycle progression after PHA stimulation Immunology. 1988;64:419-425.
20. Modiano JF, Mayor J, Ball C, Chitko-McKown CG, Sakata N, Domenico-Hahn J, Lucas JJ, Gelfand EW. Quantitative and qualitative signals determine T-cell cycle entry and progression. Cell Immunol. 1999; 197:19-29.
21. Nissen MH, Claesson MH. Proteolytically modified human beta 2-microglobulin augments the specific cytotoxic activity in murine mixed lymphocyte culture. J Immunol. 1987;139:1022-1029.
22. Neckers LM. Regulation of transferrin receptor expression and control of cell growth. Pathobiology 1991;59:11-18.
23. Akbar AN, Borthwick NJ, Wickremasinghe RG, Panayoitidis P, Pilling D, Bofill M, Krajewski S, Reed JC, Salmon M. Interleukin-2 receptor common gamma-chain signaling cytokines regulate activated T cell apoptosis in response to growth factor withdrawal: selective induction of anti-apoptotic (bcl-2, bcl-xL) but not pro-apoptotic (bax, bcl-xS) gene expression. Eur J Immunol. 1996;26:294-299.
24. Karnitz LM, Abraham RT. Interleukin-2 receptor signaling mechanisms. Adv Immunol. 1996;61:147-199.
25. Nakajima H, Shores EW, Noguchi M, Leonard WJ. The common cytokine receptor gamma chain plays an essential role in regulating lymphoid homeostasis. J Exp Med. 1997;185:189-195.
26. Malek TR, Porter BO, He YW. Multiple gamma c-dependent cytokines regulate T-cell development. Immunol Today. 1999;70:71-76.
27. Van Parijs L, Refaeli Y, Lord JD, Nelson BH, Abbas AK, Baltimore D. Uncoupling IL-2 signals that regulate T cell proliferation, survival, and Fas-mediated activation-induced cell death. Immunity. 1999;11:281-288.
28. Willermain F, Caspers-Veiu L, Baudson N, Dubois C, Hamdane M, Willem F, Bruyns C. Role and expression of CD40 on human retinal pigment epithelial cells. IOVS. 2000;41:3485-3491.
29. Schwerk C, Schulze-Osthoff K. Non-apoptotic functions of caspases in cellular proliferation and differentiation. Biochem. Pharmacol. 2003;66:1453-1458.
30. Lipinski MM, Jacks T. The retinoblastoma gene family in differentiation and development. Oncogene. 1999;18:7873-7882.
31. Müller H, Bracken AP, Vernell R, Moroni MC, Christians F, Grassilli E, Prosperini E, Vigo E, Oliner JD, Helin K. E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis. Genes Dev. 2001;15:267-285.
32. Schrum AG, Turka, LA., Palmer E. Surface T-cell antigen receptor expression and availability for long-term antigenic signalling. Immunol Rev. 2003;196:7-24.
33. Darzynkiewicz Z, Gong J, Juan G, Ardelt B, Traganos F. Cytometry of cyclin proteins. Cytometry. 1996;25:1-13.